Researchers at Waterloo Engineering are successfully using a robot to help keep children with learning disabilities focused on their work.
This was one of the key results in a new study that also found both the youngsters and their instructors valued the positive classroom contributions made by the robot.
Dystr, an AI-powered engineering platform, has launched a new product leveraging generative AI designed to automate tasks, run analysis with visualizations and perform complex calculations 10 times faster.
Co-founded by Nabeel Allana (BASc ’16, mechatronics engineering) in 2021, Dystr’s new product helps mechanical and electrical engineers write and run code in the cloud seamlessly without software experience.
Waterloo Engineering professors Dr. Kerstin Dautenhahn and Dr. Alfred Yu are among the scheduled speakers at an upcoming conference exploring the use of technology for safe and accessible health care.
Hosted by the Centre for Bioengineerng and Biotechnology at the University of Waterloo, the two-day event at the Student Life Centre will feature health researchers, clinicians and front-line workers, policy-makers and technology officers from industry.
The entrepreneurship ecosystem at Waterloo Engineering nurtures promising ideas into thriving enterprises. In our weekly Founder Fuel series, we look at new ventures and how they have benefited from that crucial early support.
Youssef Helwa (BASc ’15, nanotechnology engineering, MASc ’17, electrical and computer engineering) co-founded NERv (scheduled to be renamed FluidAI) in 2014 with Amr Abdelgawad (BASc ’16, nanotechnology engineering, MBET ’17). Their smart monitoring system detects bleeding, leaks and infections after abdominal surgery so doctors can treat complications sooner.
Therapeutic oncology company RefleXion Medical has received U.S. Food and Drug Administration (FDA) clearance for a cutting-edge treatment for early and late-stage cancers.
Founded by Dr. Samuel Mazin (BASc ’02, computer engineering) in 2009, RefleXion’s mission is to advance innovative treatment in cancer care through a biology-guided radiotherapy (BgRT) it calls SCINTIX™.
